Metalytics

Executive Summary

Metalytics is a San Diego-based private company founded in 2020, specializing in metabolic flux analysis through mapping reaction rates in diverse cell lines. The company offers unparalleled insights into cellular metabolism, serving a wide range of life science industries including biopharmaceuticals, industrial biotechnology, and research. By providing actionable data on metabolic pathway utilization, Metalytics enables clients to optimize cell line performance, improve yield, and accelerate product development. Although still in early stages with no disclosed funding rounds, the company's proprietary technology positions it as a potential leader in the niche field of metabolic flux analysis, addressing a critical need for precise metabolic characterization in cell engineering and synthetic biology. As the demand for advanced cell-based production systems grows, Metalytics is poised to capture market share by delivering high-value analytical services that reduce development timelines and enhance process understanding. The company's diagnostic applications also offer potential in identifying metabolic biomarkers for disease, expanding its addressable market beyond industrial biotech.

Upcoming Catalysts (preview)

• 2026Series A funding round60% success
• 2026Key strategic partnership with a major biopharma40% success
• 2026Launch of commercial flux analysis service platform70% success